GlassScriptPhysician profile
Denis Krutko
NPI 1457903064
$2,135.57
in general payments reported to CMS, 2019-2025
15 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what a typical Rheumatology provider received nationally (typical 2025 total: $894).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11.95 · 2022: $20.00 · 2023: $134 · 2024: $295 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,005 · Education: $99.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,004.62 |
| Education | $99.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $415.29 | 2024-2025 | Bimzelx, Cimzia |
| Amgen INC. | $401.07 | 2024-2025 | Tavneos, Uplizna, Otezla |
| Janssen Biotech, INC. | $287.04 | 2024-2025 | Tremfya, Simponi Aria |
| Novartis Pharmaceuticals Corporation | $286.72 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $262.46 | 2023-2025 | Saphnelo |
| Abbvie INC. | $230.55 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $45.12 | 2022-2025 | Jascayd |
| Genentech USA, INC. | $38.55 | 2019-2025 | Gazyva |
| Ani Pharmaceuticals, INC. | $33.82 | 2025 | Purified Cortrophin Gel |
| Takeda Pharmaceuticals U.S.A., INC. | $27.48 | 2025 | Hyqvia |
| Pharming Healthcare, INC. | $22.42 | 2025 | Ruconest |
| Genzyme Corporation | $22.16 | 2025 | |
| Pfizer INC. | $22.07 | 2025 | |
| Mallinckrodt Hospital Products INC. | $20.80 | 2025 | Acthar |
| Siemens Medical Solutions USA, INC. | $20.02 | 2024 | Acuson Juniper Diagnostic Ultrasound System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Denis Krutko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.